These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular basis of antibody-mediated neutralization and protection against flavivirus. Dai L; Wang Q; Qi J; Shi Y; Yan J; Gao GF IUBMB Life; 2016 Oct; 68(10):783-91. PubMed ID: 27604155 [TBL] [Abstract][Full Text] [Related]
5. A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection. Pierson TC; Diamond MS Prog Mol Biol Transl Sci; 2015; 129():141-66. PubMed ID: 25595803 [TBL] [Abstract][Full Text] [Related]
6. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. Dowd KA; Jost CA; Durbin AP; Whitehead SS; Pierson TC PLoS Pathog; 2011 Jun; 7(6):e1002111. PubMed ID: 21738473 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure. Andrade DV; Harris E Virus Res; 2018 Aug; 254():27-33. PubMed ID: 28655548 [TBL] [Abstract][Full Text] [Related]
8. Mapping the diverse structural landscape of the flavivirus antibody repertoire. Sevvana M; Kuhn RJ Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Pierson TC; Fremont DH; Kuhn RJ; Diamond MS Cell Host Microbe; 2008 Sep; 4(3):229-38. PubMed ID: 18779049 [TBL] [Abstract][Full Text] [Related]
11. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764 [TBL] [Abstract][Full Text] [Related]
12. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. Rey FA; Stiasny K; Vaney MC; Dellarole M; Heinz FX EMBO Rep; 2018 Feb; 19(2):206-224. PubMed ID: 29282215 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012. Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560 [TBL] [Abstract][Full Text] [Related]
14. Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition. Dowd KA; Mukherjee S; Kuhn RJ; Pierson TC J Virol; 2014 Oct; 88(20):11726-37. PubMed ID: 25078693 [TBL] [Abstract][Full Text] [Related]
15. The role of anti-flavivirus humoral immune response in protection and pathogenesis. Hurtado-Monzón AM; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; De Jesús-González LA; Reyes-Ruiz JM; Del Ángel RM Rev Med Virol; 2020 Jul; 30(4):e2100. PubMed ID: 32101633 [TBL] [Abstract][Full Text] [Related]
16. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity. VanBlargan LA; Goo L; Pierson TC Microbiol Mol Biol Rev; 2016 Dec; 80(4):989-1010. PubMed ID: 27784796 [TBL] [Abstract][Full Text] [Related]
17. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus. Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS mBio; 2016 Jul; 7(4):. PubMed ID: 27435464 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Pierson TC; Diamond MS Expert Rev Mol Med; 2008 May; 10():e12. PubMed ID: 18471342 [TBL] [Abstract][Full Text] [Related]
19. High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles. Lücke AC; Vom Hemdt A; Wieseler J; Fischer C; Feldmann M; Rothenfusser S; Drexler JF; Kümmerer BM Viruses; 2022 Feb; 14(2):. PubMed ID: 35215941 [TBL] [Abstract][Full Text] [Related]
20. Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies. Yamanaka A; Rattanaamnuaychai P; Matsuda M; Suzuki R; Matsuura Y; Tatsumi M; Konishi E Vaccine; 2022 Oct; 40(42):6004-6011. PubMed ID: 36109279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]